河北医学
河北醫學
하북의학
HEBEI MEDICINE
2014年
6期
887-889,890
,共4页
放射治疗%乳腺导管原位癌%切除手术%复发率
放射治療%乳腺導管原位癌%切除手術%複髮率
방사치료%유선도관원위암%절제수술%복발솔
Radiotherapy%Ductal carcinoma in situ%Operation%Recurrence rate
目的:探讨不予放射治疗局部切除方法治疗乳腺导管原位癌的临床疗效。方法:本文回顾性分析了我院自2003年5月至2008年4月所收治的101例乳腺导管原位癌患者,均采用局部切除方法治疗,并且不予放射治疗,根据病情分别行单纯乳房局部切除术30例、改良根治术28例、标准根治术31例、扩大根治术12例。结果:全组患者11例(10.89%)患者出现了术后的复发,复发患者均再次进行了局部或是全部的乳房切除术,并且在再次随访的过程中均没有出现复发和死亡。3年生存率100%(101/101),5年生存率97.03%(98/101)。结论:不予放射治疗局部切除方法治疗乳腺导管原位癌患者的康复与复发率的降低具有积极效果,且相对于放射治疗临床医疗费用与副作用较小,值得未来进一步临床推广。
目的:探討不予放射治療跼部切除方法治療乳腺導管原位癌的臨床療效。方法:本文迴顧性分析瞭我院自2003年5月至2008年4月所收治的101例乳腺導管原位癌患者,均採用跼部切除方法治療,併且不予放射治療,根據病情分彆行單純乳房跼部切除術30例、改良根治術28例、標準根治術31例、擴大根治術12例。結果:全組患者11例(10.89%)患者齣現瞭術後的複髮,複髮患者均再次進行瞭跼部或是全部的乳房切除術,併且在再次隨訪的過程中均沒有齣現複髮和死亡。3年生存率100%(101/101),5年生存率97.03%(98/101)。結論:不予放射治療跼部切除方法治療乳腺導管原位癌患者的康複與複髮率的降低具有積極效果,且相對于放射治療臨床醫療費用與副作用較小,值得未來進一步臨床推廣。
목적:탐토불여방사치료국부절제방법치료유선도관원위암적림상료효。방법:본문회고성분석료아원자2003년5월지2008년4월소수치적101례유선도관원위암환자,균채용국부절제방법치료,병차불여방사치료,근거병정분별행단순유방국부절제술30례、개량근치술28례、표준근치술31례、확대근치술12례。결과:전조환자11례(10.89%)환자출현료술후적복발,복발환자균재차진행료국부혹시전부적유방절제술,병차재재차수방적과정중균몰유출현복발화사망。3년생존솔100%(101/101),5년생존솔97.03%(98/101)。결론:불여방사치료국부절제방법치료유선도관원위암환자적강복여복발솔적강저구유적겁효과,차상대우방사치료림상의료비용여부작용교소,치득미래진일보림상추엄。
Objective:To investigate the clinical efficacy of local resection method without radiotherapy treatment of ductal carcinoma in situ .Method:A retrospective analysis of 101 cases of breast cancer patients in our hospital from 2003 May to 2008 April were treated by local excision , and no radiation therapy , accord-ing to the disease were treated by extended radical mastectomy in 12 cases, 31 cases of standard radical mas-tectomy , modified radical mastectomy in 28 cases , partial resection in 30 simple breast an example .Result:There were 11 patients ( 10.89%) developed recurrence ,the recurrence patients were again analyzed in par-tial or complete mastectomy ,and in the process again follow-up are not relapse and death .The 3 years sur-vival rate was 100%(101/101),5 years survival rate was 97.03%(98/101).Conclusion: The positive effect is not radiotherapy for local excision of rehabilitation treatment for patients with ductal carcinoma in situ and reduce the recurrence rate , and relative to the radiation therapy clinical medical cost and little side effect, which deserves further clinical promotion .